Sökresultat - P. A. Lebedev
- Visas 1 - 12 av 12 resultat
-
1
CORONARY ATHEROSCLEROSIS FACTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND METABOLIC SYNDROME av T. V. Krovyakova, P. A. Lebedev
Publicerad 2010-06-01The effects of lipid profile (LP) parameters on endothelium-dependent vasodilatation were studied in patients with coronary heart disease (CHD) and metabolic syndrome during the lipid load (LL) test. CHD diagnosis was confirmed by selective coronary angiography (CAG). According to CAG results, all p...
Hämta fulltext
Artikel -
2
Postprandial hyperlipidemia as a coronary atherosclerosis factor in patients with metabolic syndrome; corrective potential of rosuvastatin therapy av T. V. Krovyakova, P. A. Lebedev
Publicerad 1970-01-01Aim. To investigate the atherogenic role of postprandial hyperlipidemia (PPH) and endothelial dysfunction (ED) in the development of coronary angiosclerosis in patients with coronary heart disease (CHD) and metabolic syndrome (MS); to study the effectiveness of rosuvastatin in the correction of thes...
Hämta fulltext
Artikel -
3
From Low-Dose Fixed Combinations for Arterial Hypertension Treatment to Multi-Target Therapy of Cardiovascular Diseases av P. A. Lebedev, A. A. Garanin
Publicerad 2020-09-01The article presents the evolutionary development of combination therapy from the creation of a multicomponent tablet for the treatment of arterial hypertension (AH) to modern multi-target fixed combinations as the most effective approach to the fight against cardiovascular diseases (CVD). The prior...
Hämta fulltext
Artikel -
4
Pharmacotherapy of gout – modern approaches and prospects av P. A. Lebedev, A. A. Garanin, N. L. Novichkova
Publicerad 2021-08-01The article discusses modern approaches to the gout treatment, presented in foreign and domestic clinical guidelines. While the use of urate-lowering therapy for gout is a necessary and highly effective strategy, in the case of asymptomatic hyperuricemia, the benefits of this approach are not clear....
Hämta fulltext
Artikel -
5
NLRP3 Inflammasome — a new universal target of asymptomatic hyperuricemia and gout management av P. A. Lebedev, L. T. Volova, N. K. Osina, E. V. Paranina
Publicerad 2024-07-01From modern perspective, hyperuricemia should be considered as a trigger of inflammatory activity in tissues and organs, leading to the formation of tophi, arthropathy, kidneys and cardiovascular system damage. Similarly, hypercholesterolemia, a proven factor in atherogenesis-far from all patients l...
Hämta fulltext
Artikel -
6
Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects av P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina
Publicerad 2021-07-01Combination therapy is the standard of treatment for virtually all current non-communicable diseases, primarily chronic coronary heart disease, in modern terminology - "chronic coronary syndrome" (CSS), arterial hypertension, chronic heart failure, diabetes mellitus. The need for a combina...
Hämta fulltext
Artikel -
7
Risk factors for myocardial infarction during carotid endarterectomy in high-risk patients with coronary artery disease av A. N. Vachev, O. V. Tereshina, O. V. Dmitriev, Yu. S. Belkin, P. A. Lebedev
Publicerad 2023-01-01Aim. To determine the value of various risk factors for predicting the myocardial infarction (MI) during carotid endarterectomy in high-risk patients with coronary artery disease (CAD).Material and methods. The single-center cohort prospective study included 204 high-risk patients with CAD who requi...
Hämta fulltext
Artikel -
8
The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market av I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya
Publicerad 2025-05-01Objective: to study the characteristics of the population consumption of medicines for the treatment of diabetes mellitus (DM), sold in the retail sector of the pharmaceutical market of the Russian Federation (RF).Material and methods. The study analyzed data on products assortment and sales volumes...
Hämta fulltext
Artikel -
9
The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 av I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova
Publicerad 2022-04-01Objective: to determine the compliance of antihypertensive drugs consumption with the trends of modern pharmacotherapy.Material and methods. The analysis of the consumption level of antihypertensive drugs, their fixed combinations (FC), as well as statins in the retail sector of the pharmaceutical m...
Hämta fulltext
Artikel -
10
CONSUMPTION DETAILS OF SYSTEMICALLY ACTING ANTIVIRAL AND ANTIMICROBIAL PREPARATIONS IN PERIOD OF NOVEL CORONAVIRUS INFECTION SPREAD IN RETAIL SECTOR OF SAMARA REGION PHARMACEUTICAL... av I. K. Petrukhina, P. A. Lebedev, I. I. Sirotko, T. K. Ryazanova, E. P. Gladunova, A. A. Garanin
Publicerad 2022-12-01An analysis of the medicinal preparation consumption structure in the period of the COVID-19 pandemic in the pharmacy network reflects the existing outpatient practice and makes it possible to draw generalized conclusions about its compliance with the pharmacotherapy standards.The aim. Comparative a...
Hämta fulltext
Artikel -
11
Cell-based <i>in vitro</i> hemoassay for evaluation of NLRP3-inflammasome activity av N. K. Ossina, L. T. Volova, P. A. Lebedev, I. A. Shafieva, E. I. Pugachev, S. A. Goncharenko, S. I. Kuznetsov, O. A. Gusyakova, G. N. Svetlova
Publicerad 2024-09-01Currently, gouty arthritis is considered as a polygenic multifactorial autoinflammatory disease caused by activation of the NOD (nucleotide-binding domain) -like protein receptor 3 inflammasome NLRP3. The two cytokines IL-1β and IL-18 are considered important biomarkers of NLRP3 inflammasome activat...
Hämta fulltext
Artikel -
12
ARTERIAL HYPERTENSION WORKGROUP RESOLUTION. THE ROLE OF SARTANS IN TREATMENT OF SYSTEMIC HYPERTENSION IN THE 21ST CENTURY av A. O. Konradi, O. N. Zhdanova, O. P. Rotar, Yu. A. Karpov, V. I. Podzolkov, P. A. Lebedev, A. I. Chesnikova, D. V. Nebieridze, O. N. Miller, E. V. Solovjova, A. N. Kulikov
Publicerad 2018-04-01.
Hämta fulltext
Artikel